Tumors from three HCC patients (HCC-1, HCC-2, and HCC-3) were confirmed to express high levels of CDC37 compared to their matched non-tumor liver tissues (Fig. 4A). This evidence concerns the gene CDC37 and hepatocellular carcinoma.